Indego Information

With dedicated therapy and personal use exoskeletons, Indego provides solutions that address the complete continuum of care - from acute rehabilitation to home and community ambulation. Indego Therapy is cleared by the FDA for use with spinal cord injury patients with injury levels C7 to L5, and for individuals with hemiplegia (with motor function of 4/5 in at least one upper extremity) due to cerebrovascular accident (CVA) to perform ambulatory functions in rehabilitation institutions. Indego Personal is cleared by the FDA to enable individuals with spinal cord injury at levels T3 to L5 to perform ambulatory functions in their home and community. The recently released VA memorandum "Revised Clinical Protocol for Issuance of Powered Exoskeleton Devices to Veterans with Spinal Cord Injury" (found at www.sci.va.gov) expands the protocol for veteran evaluation, training and issuance for personal use exoskeletons to all FDA approved devices, including Indego.